Every other year, for more than two decades, a small group of 70 or so scientists have been meeting at different locales across the globe to discuss their speciality: aluminum and its effects on living things. The science of a metal used in industries from airplane manufacturing to food packaging may sound tedious, but this three-day Keele meeting (named for Keele University in the United Kingdom where it originated) produces a treasure trove of valuable information about the health impact of aluminium exposure. It’s a conference of the latest science that the $186 billion aluminum industry denies and public health agencies pretend does not exist. The 12th Annual Keele Meeting on Aluminum last week in Vancouver, Canada, sponsored by the Children’s Medical Safety Research Institute, was no exception. Scientists from 16 countries discussed the latest research about how aluminum impacts plants, animals and humans. We inhale it in pollution, consume it in processed foods, slather it on in toiletries and inject it into ourselves and our babies in vaccines. Neurotoxic aluminium, according to increasing amount of scientific evidence, may stay in the body where it breaches protective barriers, induces wildly oxidative processes and fires inflammation, disrupts genetic transcription, impairs metabolism, accumulates in brain and breasts and testes, is linked to cancer, infertility, Alzheimer’s disease and anxious, aggressive and autistic behaviour.
There have been unconfirmed suspicions that aluminum toxicity is at least a factor for dementia and Alzheimer’s disease. There seems to be no doubt that aluminum is a neurotoxin, but whether there is an aluminum link to Alzheimer’s and other forms of dementia, has not been fully explored just recently. A new study, “Aluminium [British spelling] in brain tissue in familial Alzheimer’s disease” does just that. A pathological brain study of deceased individuals whose bodies were donated by family members. It was conducted in King’s College of London and Keele University of Staffordshire, UK, and published December 2016 in the Journal of Trace Elements in Medicine and Biology. The study’s conclusion: "Aluminium is neurotoxic and the concentrations of aluminium found in these familial AD brains are unlikely to be benign and indeed are highly likely to have contributed to both the onset and the aggressive nature of any ongoing AD in these individuals. These data lend support to the recent conclusion that brain aluminium will contribute towards all forms of AD under certain conditions."
On September 28, 2016 the Daily Mail Online reported that scientists in Reading had discovered a possible link between antiperspirants and breast cancer. To my knowledge, this is the first time that a report has mentioned that the use of these products containing aluminum in prepubescent and teenage children may not only be a risk for breast cancer, but also disrupts their hormonal development and is linked to other health problems.
Health authorities and the media relentlessly repeat the mantra that vaccines are unequivocally safe, and many uninformed consumers cling to this mantra like a lifeboat. More often than not, however, consumers know little or nothing about the vaccine safety testing process and assume that vaccine manufacturers and regulatory institutions have exercised due diligence in ensuring that vaccines are as safe as possible. In an ordinary clinical trial, investigators compare a group that receives a drug with another group that receives a harmless placebo. Not so with vaccine clinical trials, many of which use placebos that contain an aluminum adjuvant. What are the implications of using aluminum-based placebos that are not innocuous or inert but instead are “intrinsically capable of stimulating pathological immune and neuro-inflammatory responses”? This is one of the critically important questions that Dr. Yehuda Shoenfeld and colleagues at Tel Aviv University and University of British Columbia researchers Lucija Tomljenovic and Christopher Shaw address in a July 2016 study in Immunologic Research about aluminum adjuvants and the quadrivalent Gardasil vaccine that ostensibly protects against four types of human papillomavirus (HPV). Dr. Shoenfeld and colleagues begin and end with the assertion that aluminum-containing placebos represent both a scientifically and ethically inappropriate choice for vaccine clinical trials, given aluminum’s well-documented neuro- and immunotoxic properties.
With U.S. doctors questioning the safety and effectiveness of the new meningitis B vaccines in a shocking San Diego Union Tribune news report, we need to ask ourselves whether or not our children are more at risk from the vaccine, than they are from the disease itself. This is a real possibility because according to the Tribune, risk of catching the disease is rare and patients from families with a history of immune system disease could be at risk from severe adverse reactions. Dr. Mark Sawyer, an infectious disease specialist at Rady Children’s Hospital in San Diego, told reporters: “Newer vaccines on the market lack comprehensive evidence on safety and effectiveness, compared with vaccines that have been administered to tens of millions of people over decades.” Furthermore, he continued by informing reporters that he did not vaccinate his own daughter because he did not feel that she was at an increased risk and stated: “Parents should realize that there are many more pressing threats on the vaccination front.”
Have you ever wondered why so many people, in particular those over the age of 65, react adversely to the flu vaccination? How many times have you heard that, after receiving the flu vaccine, a friend or loved one has developed flu-like symptoms? At last, after many years of speculation, scientists in London believe they have the answer to our questions.
Dr. Suzanne Humphries has made available to the public her lecture on neonatal immunity presented in New Zealand in May of 2014. In this lecture, Dr. Humphries deals specifically with the toxic effects of aluminum, which is a common adjuvant contained in childhood vaccines. The medical literature clearly shows that aluminum is a death factor for cells, and highly toxic. The reasons as to why aluminum has not been replaced with something less toxic or non-toxic are economical, and not medical. This is a critical lecture that anyone considering vaccines needs to watch, particularly pregnant women and parents of young children.
Aluminum is a known neurotoxin, and according to Professor Christopher Exley of Keele University, aluminum-containing products are likely fueling the rise in Alzheimer's disease. People with aluminum toxicity display many of the same symptoms as those with dementia, Parkinson’s, ADHD, autism, and other neurological diseases, and mounting evidence suggests aluminum may play a significant role in the development of those (and other) diseases. Other toxins to beware of include fluoride and glyphosate. All of these are toxic in their own right, but research suggests they may be even more hazardous in combination.
While "anti-vaxxers" are being smeared in public campaigns as backward and unscientific fear-mongers, a growing body of cutting edge research is emerging from the top echelons of medical immunology to confirm what the "cranks" have been saying for years about the devastating effects of vaccine ingredients. The biggest names in the field of study of the human immune system are attached to current papers in the most prestigious immunology literature that link widely used vaccine ingredients such as aluminum to terrifying modern epidemics of immune-mediated diseases including autism and Alzheimer's.
Newly published research by Keele Conference scientists shows that aluminum adjuvant in vaccines transfers to the brain.